Pulmonary Mucormycosis
📧 Sign up to get email alerts when something new happens for Pulmonary Mucormycosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value
A recruiting clinical study from University Hospital Strasbourg is evaluating the prognostic value of chest CT scans in patients with pulmon…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Antifungal Drugs in Pulmonary Mucormycosis [Phase 4]
Phase 4 clinical trial update studying antifungal drugs for pulmonary mucormycosis, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Amphotericin Versus Posaconazole for Pulmonary Mucormycosis [Phase 2]
A Phase 2 clinical trial comparing amphotericin B with posaconazole for pulmonary mucormycosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Efficacy and Safety of Systematic Therapy and Bronchoscopic Interventional Treatment for Pulmonary Mucormycosis [NA]
The document provides an update on a clinical trial assessing systemic therapy and bronchoscopic interventional treatment for pulmonary muco…
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis [Phase 2]
Phase 2 trial comparing inhalational plus intravenous amphotericin B versus intravenous amphotericin B alone for pulmonary mucormycosis has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.